Production of first generation adenovirus vectors: a review. - Wikidata - wikimedia - TriplyDB

Production of first generation adenovirus vectors: a review.

Production of first generation adenovirus vectors: a review.

http://www.wikidata.org/entity/Q34085243

about

Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.Gutless adenovirus: last-generation adenovirus for gene therapy High-efficiency system for the construction of adenovirus vectors and its application to the generation of representative adenovirus-based cDNA expression libraries.Molecular engineering of viral gene delivery vehicles Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein.Gene therapy for cardiovascular disorders: is there a future?Tracking expression of virally mediated BMP-2 in gene therapy for bone repair.Recombinant adenovirus-mediated cytotoxic gene therapy of lymphoproliferative disorders: is CAR important for the vector to ride?Advances in Gene Delivery Systems.Duchenne muscular dystrophy gene therapy in the canine model.A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation.Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.Use of adenoviral vectors as veterinary vaccines.Hyperthermia and gene therapy: potential use of microPET imaging.Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.Bipartite vector encoding hVEGF and hIL-1Ra for ex vivo transduction into human islets Switching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.Vectorology and factor delivery in induced pluripotent stem cell reprogramming.Vaccines: A review of immune-based interventions to prevent and treat disease.Helper-Dependent Adenoviral Vectors and Their Use for Neuroscience Applications.pUNISHER: a high-level expression cassette for use with recombinant viral vectors for rapid and long term in vivo neuronal expression in the CNS.Assessment of Specificity of an Adenovirus Targeted to HER3/4.Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.Efficient cell reprogramming using bioengineered surfaces.Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted.Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells.Adenoviral type 35 and 26 vectors with a bidirectional expression cassette in the E1 region show an improved genetic stability profile and potent transgene-specific immune response.Structural and biochemical characterization of a human adenovirus 2/12 penton base chimera.Preferable sites and orientations of transgene inserted in the adenovirus vector genome: The E3 site may be unfavorable for transgene position.Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus.Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck.Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.Advancements in the design and scalable production of viral gene transfer vectors.Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cells.Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.Enhanced adenovirus transduction of hMSCs using 3D hydrogel cell carriers.

P2860

Q26750912-AED18BAF-DE12-4990-A69D-EF04A203163F Q27469506-D9272149-ED47-4438-A5F6-E323E9C091D5 Q28277560-0A838D79-CFB4-47FC-B5FF-992D0EFDE884 Q30815080-B9D0B33E-EB40-4A17-847C-629017721921 Q33353795-23551702-70B4-4D62-A067-EEEDCC0BD662 Q34110625-74BDB4F4-239C-4523-9A79-813965A6C926 Q34497315-9405FE00-D60F-48EC-AE1F-64FD14CD1CDA Q34918341-7DD70636-8CD3-4891-ABB5-9F892123FF7A Q35061703-A61715DA-1DA5-44B0-89E8-A8D1599B5E1F Q35632772-F4202359-5E1E-43D8-9937-7735B59C0C17 Q35641673-083BAC3E-FF39-42C3-A0B6-18A0609E416C Q36255250-F2CABCE3-B086-4468-96F5-28EA836FE562 Q36267811-E46472E8-E8C4-45D5-9EA9-199004F62810 Q36288920-2F49DE45-C9E7-408D-81C8-C5ED5D3AEF88 Q36288927-1FCD4547-21EE-4C3D-AD9B-B97B15BCAA29 Q36497619-A456940A-6F9D-4F71-A28E-3E1E3EF4B2E9 Q36960666-AA6923EB-7FB0-47D1-A06E-D8ED36D8DB45 Q37254994-E9167297-5473-4407-8B95-6AF0A437FDE1 Q37547783-55537295-7B3F-400E-AA4B-B5765F713850 Q38195650-2C8C1B17-4E5E-45F3-9AEE-588C9C60F52D Q38364468-BC33D465-1A70-4433-ABF1-9A0CE5FF29E4 Q38436558-372426AC-9544-47CB-AAF3-B3BA5CE87D5D Q38461882-B4C660F5-A91B-486F-AE7E-24EAF141C98B Q38645041-6293A037-B796-4B85-8378-308C4945482D Q38728732-470ACBB3-9AD8-4FDE-8328-ED238B3733E0 Q39237811-FE5A67EC-B8EF-4990-9BDF-04FB6AF6CC36 Q39683618-83AB6814-2C00-42C7-8027-FB24C9AE862E Q39827116-355C36FB-E7D9-4A3A-AD13-CD900CC86FE5 Q40080155-05F03F24-601C-477A-A515-337729E7C172 Q40238566-25BB4A52-8D8C-4106-8B32-728D4DECBC17 Q40448157-B7292277-776A-4493-836B-7235AD824371 Q40669254-E94CDB5B-28CC-459A-B79D-4C21AC859C95 Q41218508-6A49F881-2A1F-49E9-969C-23B97A84403C Q41242033-25EBDA88-949A-4129-8C06-537E9AD7B51C Q41699782-CE0CCF68-5D8A-4675-A38E-F5BA91CD25C3 Q41900379-6CF6EA50-7E3B-44D6-B7BC-ED37022189A3 Q41931475-9EF001F9-9873-43DA-BF58-2114C81E972B Q44570719-545D90C9-8EC9-4AE4-8300-276A9D8345B4 Q44620329-53698CB4-275A-4BE6-9BE9-28759F18D5F2 Q45877559-D73E102B-AA41-4CC6-87B7-7213F1848F4E

P2860

Production of first generation adenovirus vectors: a review.

http://www.wikidata.org/entity/Q34085243

description

2000 nî lūn-bûn

@nan

2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

name

Production of first generation adenovirus vectors: a review.

@ast

Production of first generation adenovirus vectors: a review.

@en

Production of first generation adenovirus vectors: a review.

@nl

type

label

Production of first generation adenovirus vectors: a review.

@ast

Production of first generation adenovirus vectors: a review.

@en

Production of first generation adenovirus vectors: a review.

@nl

prefLabel

Production of first generation adenovirus vectors: a review.

@ast

Production of first generation adenovirus vectors: a review.

@en

Production of first generation adenovirus vectors: a review.

@nl

P1433

Q34085243-F071F622-2811-4603-AEF2-604F643503CD

P1476

Q34085243-92B3DF4D-D1CE-4EAD-90CB-6A9A47229DF7

P2093

Q34085243-18F96EC3-5A82-427F-93C2-F83398343652

Q34085243-1DA7FCDB-42A1-4460-BAB8-FFDE9C5E9E81

P2860

Q34085243-07ABFE13-314B-475A-9982-8731AD6DC5B1

Q34085243-0B0875BB-6692-4DD5-A8E7-3CB5EFCB7300

Q34085243-1CA4E855-1726-4E9E-A7A9-F8465964A439

Q34085243-1E45DD1F-6797-4BD8-BBEE-6902CF72E821

Q34085243-24DDA069-D4EF-4147-83E2-AC662348EB2E

Q34085243-29BE89B8-38E7-4D61-AA2F-F70875C467B1

Q34085243-45115D97-9D68-42A0-8D1F-DA991BD53CB2

Q34085243-4B89B6C6-409F-4C7C-8E33-D3F713BA5A9D

Q34085243-4C189977-F52B-4998-AE58-C1FBED3F0392

Q34085243-57E67CEC-9CB7-4D23-8651-3940A189D832

P2888

Q34085243-882F9B3F-E257-46AF-96AA-E93CFAF9BFD9

P304

Q34085243-6588B4E3-35D6-4860-A260-0FC8D6F46A5F

P31

Q34085243-197BA818-9335-4DB5-A8DC-8812FDB56F54

P356

Q34085243-012A6649-8CC9-4733-B262-FC2B71C9552A

P433

Q34085243-F7707D0F-FE14-4DAC-A2BE-B97E5ACEAACE

P478

Q34085243-D4F7F23E-00E6-47F8-9A2D-0912BA2FC6B7

P577

Q34085243-CF5D10E1-4BE1-4981-87BC-EB472FC81C2F

P5875

Q34085243-A3FE25AA-42C9-4DD8-8DE7-622674494457

P698

Q34085243-2E993A41-3471-4DD5-8AEB-7161937744BB

P921

Q34085243-EE880390-AD56-4C51-AEFA-AAA938A3A357

P356

P1433

P1476

Production of first generation adenovirus vectors: a review.

@en

P2093

Danthinne X

http://www.w3.org/2001/XMLSchema#string

Imperiale MJ

http://www.w3.org/2001/XMLSchema#string

P2860

A simplified system for generating recombinant adenoviruses

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome.

Adenovirus vectors for gene delivery.

Processive proofreading by the adenovirus DNA polymerase. Association with the priming protein reduces exonucleolytic degradation

Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone.

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

Recombinational construction in Escherichia coli of infectious adenoviral genomes

P2888

P304

1707-1714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3301301

http://www.w3.org/2001/XMLSchema#string

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2000-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12243285

http://www.w3.org/2001/XMLSchema#string

P698

11083491

http://www.w3.org/2001/XMLSchema#string

P921